1. Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma.
- Author
-
Feely S, Mullen N, Donlon PT, Reidy E, Challapalli RS, Hassany M, Sorushanova A, Martinez ER, Owens P, Quinn AM, Pandit A, Harhen B, Finn DP, Hantel C, O'Halloran M, Prakash P, and Dennedy MC
- Subjects
- Humans, Cell Line, Tumor, Mitotane pharmacology, Tumor Microenvironment, Collagen Type I metabolism, Collagen Type I genetics, Cell Culture Techniques methods, Adrenocortical Carcinoma pathology, Adrenocortical Carcinoma metabolism, Adrenocortical Carcinoma genetics, Adrenal Cortex Neoplasms pathology, Adrenal Cortex Neoplasms metabolism, Adrenal Cortex Neoplasms genetics, Cell Culture Techniques, Three Dimensional methods, Cell Proliferation, Cell Survival
- Abstract
Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex that is associated with a poor prognosis. Developing effective treatment options for ACC is challenging owing to the current lack of representative preclinical models. This study addressed this limitation by developing and characterizing 3-dimensional (3D) cell cultures incorporating the ACC cell lines, MUC-1, HAC15, and H295R in a type I collagen matrix. ACC tissue samples were analyzed by immunohistochemistry to determine the presence of type I collagen in the tumor microenvironment. Cell viability and proliferation were assessed using flow cytometry and confocal microscopy. mRNA expression of steroidogenic enzymes and steroid secretion was analyzed by comparing the 3D and monolayer cell culture models. All cells were successfully cultured in a type I collagen matrix, which is highly expressed in the ACC tumor microenvironment and showed optimal viability until day 7. All 3 models showed increased metabolic and proliferative activity over time. Three-dimensional cell cultures were steroidogenic and demonstrated increased resistance to the gold standard chemotherapy, mitotane, compared with monolayer. The use of these models may lead to an improved understanding of disease pathology and provide a better representative platform for testing and screening of potential therapies., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.)
- Published
- 2024
- Full Text
- View/download PDF